GTHX +36% on phase-2 data in TNBC: https://www.globenewswire.com/news-release/2019/06/18/1870085/0/en/G1-Therapeutics-Announces-Updated-Results-from-Phase-2-Trial-of-Trilaciclib-in-Combination-with-Chemotherapy-Showed-Statistically-Significant-Improvement-in-Overall-Survival-in-Wom.html